Follicular Non-Hodgkin's Lymphoma
Also known as: Non-Hodgkin Lymphoma, Follicular Lymphoma / Follicular B-cell Non-Hodgkin's Lymphoma / Follicular B-cell non-Hodgkin lymphoma / Follicular non-hodgkin lymphoma / Nodular (follicular) lymphoma / Non Hodgkin's Follicular Lymphoma / Non-Hodgkin Lymphoma, Follicular (Nodular) / Follicular lymphoma, unspecified / Follicular lymphoma / Follicular lymphomas / Nodular lymphoma (disorder) / Follicular low grade B-cell lymphoma (disorder) / Nodular lymphoma / Malignant lymphoma, centroblastic-centrocytic, follicular (disorder) / Follicular lymphoma (morphologic abnormality) / Lymphoma, Follicular / Follicular non-Hodgkin's lymphoma (disorder)
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB00078 | Ibritumomab tiuxetan | A monoclonal anti-CD20 antibody used to treat B-cell non-Hodgkin's lymphoma via a conjugated radioactive isotope. |
| DB05258 | Interferon alfa | An immunomodulator used to treat hepatitis B and C as well as certain types of cancer including cutaneous T-cell lymphoma and renal cell carcinoma. |
| DB00105 | Interferon alfa-2b | A form of recombinant human interferon used to treat hepatitis B and C infection, genital warts, hairy cell leukemia, follicular lymphoma, malignant melanoma, and AIDs-related Kaposi's sarcoma. |
| DB00073 | Rituximab | A monoclonal anti-CD20 antibody used to treat non-Hodgkin's lymphoma, chronic lymphocytic leukemia, Wegener's granulomatosis, pemphigus vulgaris, and rheumatoid arthritis. |
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB17366 | MB-102 CD123 CAR | Not Available | Terminated | 1 |
| DB11595 | Atezolizumab | 1 / 2 | Completed | 1 |
| DB15434 | Mosunetuzumab | 1 / 2 | Completed | 1 |
| DB16409 | Tiragolumab | 1 / 2 | Completed | 1 |
| DB06769 | Bendamustine | 2 | Terminated | 1 |
| DB00188 | Bortezomib | 2 | Completed | 1 |
| DB16741 | Bortezomib D-mannitol | 2 | Completed | 1 |
| DB08870 | Brentuximab vedotin | 2 | Terminated | 1 |
| DB00073 | Rituximab | 2 | Completed | 1 |
| DB00073 | Rituximab | 2 | Terminated | 1 |
| DB11581 | Venetoclax | 2 | Completed | 1 |
| DB06769 | Bendamustine | 3 | Completed | 1 |
| DB00531 | Cyclophosphamide | 3 | Completed | 1 |
| DB00997 | Doxorubicin | 3 | Completed | 1 |
| DB00078 | Ibritumomab tiuxetan | 3 | Completed | 1 |
| DB00635 | Prednisone | 3 | Completed | 1 |
| DB00073 | Rituximab | 3 | Completed | 2 |
| DB00541 | Vincristine | 3 | Completed | 1 |